Status:
ACTIVE_NOT_RECRUITING
Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation
Lead Sponsor:
University of Florida
Collaborating Sponsors:
Transplant Genomics, Inc.
Conditions:
Transplant Complication
Eligibility:
All Genders
18-90 years
Brief Summary
To develop a prospective quantitative liver allograft monitoring protocol and retrospectively validate the use of Phenotypic personalized medicine (PPM) in immunosuppression dosing in liver transplant...
Detailed Description
The investigators have developed a computational approach, Phenotypic Personalized Medicine (PPM), to utilize empiric clinical data to construct patient-specific visual maps that represent each indivi...
Eligibility Criteria
Inclusion
- At least 18 years of age
- At least one-month post-transplant
- Recipient of a liver transplant alone or a simultaneous liver-kidney transplant
Exclusion
- Unwilling to provide informed consent
- Recipient of a previous bone marrow or stem cell transplant
- Pregnant
- Unlikely to be able to comply with the study requirements, as determined by the PI
Key Trial Info
Start Date :
December 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06063213
Start Date
December 15 2023
End Date
October 15 2026
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32608